PDJ amplicon in triple negative breast cancer

Amplification of chromosome 9p24.1 targeting PD-L1, PD-L2, and JAK2 (PDJ amplicon) is present in subsets of triple negative breast cancers (TNBCs) and is associated with poor clinical outcomes. However, the prevalence of PDJ+ TNBCs varies extensively across studies applying different methods for int...

Descripción completa

Detalles Bibliográficos
Autores principales: Roesler, Alexander S., Malasi, Smriti, Koslosky, Lori, Hartmayer, Peter, Naab, Tammey J., Carter, Jodi M., Zahrieh, David, Hillman, David, Leon-Ferre, Roberto A., Couch, Fergus J., Goetz, Matthew P., Anderson, Karen S., Pockaj, Barbara A., Barrett, Michael T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837184/
https://www.ncbi.nlm.nih.gov/pubmed/36635351
http://dx.doi.org/10.1038/s41598-023-27887-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837184/
https://www.ncbi.nlm.nih.gov/pubmed/36635351
http://dx.doi.org/10.1038/s41598-023-27887-8

Ejemplares similares